Prilactone Next
Active substance
ATC code
Species
Dogs
Indications
For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by degenerative mitral valve disease in dogs.
Dose to be administered and administration route
2 mg of spironolactone per kg of body weight once daily, i.e. 1 tablet per 5 kg of body weight, by oral route. The product should be administered with meal.
|
Dog weight (kg) |
Prilactone Next 10 mg Number of tablets per day |
|
> 1 to 2.5 |
½ |
|
> 2.5 to 5 |
1 |
|
> 5 to 7.5 |
1 ½ |
|
> 7.5 to 10 |
2 |
The tablets are flavoured. If the dog does not accept the tablet from hand or bowl, then the tablets may be mixed with a small amount of food offered prior to the main meal, or administered directly into the mouth after feeding.
Adverse reactions
|
Very common (>1 animal / 10 animals treated): |
Prostatic atrophy1 |
|
Common (1 to 10 animals / 100 animals treated): |
Vomiting, Diarrhoea |
1in entire male dogs, reversible
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 15052/5063 |
| EAN | 3411112265633 |
